About Bio-Path
Overview
Leadership
Board of Directors
Scientific Advisory Board
Partnering Opportunities
Technology
Pipeline
Pipeline
Prexigebersen
BP1001-A
BP1002
BP1003
Patients
Investors
Overview
SEC Filings
Corporate Governance
Media
Press Releases
Events
Presentations & Publications
Careers
Contact Us
SEC Form 8-K: Press Release dated July 8, 2024
BPTH_8-K_07112024
SEC Form 8-K: Press Release dated June 14, 2024
BPTH_Form_8-K_06-14-24_Press_Release
SEC Form 424b3 Prospectus – June 14, 2024
BPTH_Prospectus_Resale_June_2024_PIPE
Download
SEC Form 8-K: re Nasdaq Extension
BPTH_Form_8-K_Nasdaq-Extension
SEC Form S-3
BPTH_Form_S-3_Resale_Registration_Statement_20240611_PIPE
SEC Form 8-K: Press Release dated June 5, 2024
BPTH_8-K_20240605
SEC Form 8-K: Press Release dated June 3, 2024
BPTH_20240602_8-K
SEC Form 8-K: Press Release dated May 23 & May 24, 2024
BPTH_20240530_8-K
SEC Form 8-K: Press Release May 15, 2024
BPTH-Form_8-K_Q1-2024_Earnings_Release
SEC Form 10-Q for Period ending March 31, 2024
BPTH-Form_10-Q_Q1_2024
About Bio-Path
Overview
Leadership
Board of Directors
Scientific Advisory Board
Partnering Opportunities
Technology
Pipeline
Pipeline
Prexigebersen
BP1001-A
BP1002
BP1003
Patients
Investors
Overview
SEC Filings
Corporate Governance
Media
Press Releases
Events
Presentations & Publications
Careers
Contact Us